Regístrese
Buscar en
Enfermería Clínica
Toda la web
Inicio Enfermería Clínica Self-efficacy, depression, and adherence to antiretroviral therapy (ART) among I...
Información de la revista
Vol. 29. Núm. S2.
The Second International Nursing Scholar Congress (INSC 2018) of Faculty of Nursing, Universitas Indonesia.
Páginas 687-690 (Septiembre 2019)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
114
Vol. 29. Núm. S2.
The Second International Nursing Scholar Congress (INSC 2018) of Faculty of Nursing, Universitas Indonesia.
Páginas 687-690 (Septiembre 2019)
DOI: 10.1016/j.enfcli.2019.04.105
Acceso a texto completo
Self-efficacy, depression, and adherence to antiretroviral therapy (ART) among Indonesian women with HIV
Visitas
...
Sandra Andinia,b, Sri Yonaa,
Autor para correspondencia
sriyona@ui.ac.id

Corresponding author.
, Agung Waluyoa
a Faculty of Nursing, Universitas Indonesia, Depok, West Java, Indonesia
b Dr. H. Abdul Moeleok Hospital, Lampung, Bandar Lampung, Indonesia
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Abstract
Objective

This study aimed at investigating the relationship between self-efficacy, depression, and adherence to antiretroviral therapy (ART) in Indonesian women with HIV.

Method

This study employed a cross-sectional research design. The participants were 120 women with HIV aged 18–60 years on self-administered ART regimens.

Results

This study shows a significant relationship between self-efficacy and adherence to ART (p-value=0.004; OR 2.330). Women are living with HIV with high self-efficacy adherence to following their ART 2.33 times more often than those with low self-efficacy. It is shown that a significant relationship exists between depression and adherence to ART (p-value=0.001; OR 3.647). Depressed HIV women took ART medication 3.64 times less often than who did not have depression.

Conclusion

It is recommended to increase the level adherence rate by improving self-efficacy and reduce depression.

Keywords:
Adherence
Depression
Self-efficacy
Women
HIV
Texto completo
Introduction

The World Health Organization (WHO) noted that there approximately as 36.7 million people living with HIV (PLWH) as of July 2017, 51.5% of whom were women, of these 20.9 million were undergoing antiretroviral therapy (ART), with an estimated 60% being women.1 In Indonesia in March of 2017, HIV with ART 79833, with number loss to follow up (LTFU) ART of 35521.2 Patient LTFU from ART could have serious consequences, such as non-adherence and drug resistance.3 Lampung, a province in Indonesia, accounts for a large number of HIV cases. In 2017, the number of HIV sufferers in Lampung increased to 2002 with 1320 using ART, 413 of whom were women.2

When beginning ART, PLWH must be prepared for and have a solid understanding of its consequences. This is because ART is a lifelong process that has side effects and requires adherence.4 Adherence of HIV patients to their medication regimens will bring optimal results, while a low level of adherence will make the virus resistant to the drug.5,6

PLWH's adherence to ART can be affected by their self-efficacy. The higher their self-efficacy, the better their adherence to the treatment.7,8 If individuals have a high self-efficacy, they will manage their situation more effectively and will how to handle it.9,10 Self-efficacy in women living with HIV (WLWH) can affect their lives, enables them to access resources, allows them to use their skills, empowers them to overcome difficulties, and helps them maintain their health.11,12

Adherence to ART can also be affected by depression. Some studies found that PLWH who are depressed tend not to adhere to treatment. This is because, with ART, PLWH can feel depressed and view it negatively, focusing on its side effects, fearing that it will reveal them as HIV patients, and believe that ART is toxic to the body.13 WLWH often experience depression because they feel ashamed and isolated, have stigmas toward HIV, experience high levels of anxiety, have difficulties in their dual roles as mother and wife and lack social support and coping skills.14,15

Adherence with ART is the key to extending the life expectancy of PLWH. Women can transmit HIV to their partners and fetuses if they do not adhere to the ART regimen. Based on this rationale, a study of the relationship between self-efficacy, depression, and adherence to ART in women with HIV is necessary.

MethodParticipants and procedure

A total of 120 women with HIV were enrolled in this study. The sampling technique used was non-probability sampling, consecutive sampling in particular. Participants were recruited at one Voluntary Counselling and Testing (VCT) Clinic at the Dr. H. Abdul Moeloek Hospital in Lampung. This VCT Clinic provides HIV testing and care. The study's inclusion criteria called for women over 18 years old who had undergone ART for more than 6 months and could read and write. The exclusion criteria were HIV-positive women who suffered from mental disorders, such as schizophrenia, delusions, and hallucinations. This research was conducted in May of 2018.

Measures

Variable adherence was measured using the Four-Item Morisky–Green–Levine Medication Adherence Scale (MGL-MAS). Values of 1–4 indicated no adherence and a value of 0 indicated adherence.16 We calculated a correlation coefficient of 0.374–0.393 and a Cronbach's alpha value of 0.6. Variable self-efficacy was measured using the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES) with a cut-off point median of 115. Values of 1–114 indicated low self-efficacy, and values of 115–120 indicated high self-efficacy.17 The correlation coefficient of the validity test was calculated at 0.802–0.941, and its Cronbach's alpha value was 0.979. Depression was measured by the Center for Epidemiologic Studies Depression (CES-D) Scale.18 Total scores of 1–16 indicated that respondents were not depressed, and total scores of 17–60 showed that respondents were depressed. The correlation coefficient of the validity test was >0.4 (r=0.444), and the Cronbach's alpha value was 0.934. All questionnaires were translated into the Indonesian language.

Data statistics

Bivariate analysis was conducted to identify the relationship between self-efficacy, depression, and adherence to ART. This study used the chi-squared test because the data for each variable is categorical. The degree of significance in this study was 95%, or α 0.05. Ethical approval was given by the Universitas Indonesia Faculty of Nursing Ethics Committee (No. 151/UN2.F12. D/HKP.02.04/2018).

Results

Most respondents were 18–40 years old (81.7%), were unemployed (79.2%), were married (66.7%), and had received ART for more than 12 months (90%). Additionally, most respondents had high self-efficacy (61.7%), experienced depression (57.7%), and had adherence to ART (52.5%) (Table 1).

Table 1.

Distribution of respondents based on sociodemographic, duration of treatment, side effects, alcohol use, compliance, self-efficacy, and depression (N=120).

Variable  Frequency  Percentage 
Age
18–40 years old  98  81.7 
41–60 years old  22  18.3 
Level of education
Junior high school  32  26.7 
Middle high school  67  55.8 
Senior high school  21  17.5 
Employment
Unemployed  95  79.2 
Employed  25  208 
Marital status
Single  2.5 
Married  80  66.7 
Widowed  37  30.8 
Length of treatment
6–12 months  12  10 
>12 months  108  90 
Side effects
No side effects  77  64.2 
Some side effects  43  35.8 
Alcohol use
Do not drink alcohol  119  99.2 
Drink alcohol  0.8 
Adherence
No adherence  63  52.5 
Adherence  57  47.5 
Self-efficacy
Low self-efficacy  46  38.3 
High self-efficacy  74  61.7 
Depression
Depression  53  43.3 
No depression  67  57.7 

Bivariate analysis revealed a significant relationship between self-efficacy and adherence to ART (p-value=0.004; α 0.05) with an OR value of 2.330 (1.089–4.983). This indicated that WLWH with high self-efficacy were 2.33 times more likely to adherence to ART than were those with low self-efficacy. Statistical tests also indicated a significant relationship between depression and adherence to ART (p-value=0.001; OR 3.647; 1.697–7.837). Depressed women were 3.64 times more likely to not adherence to ART than were women who were not depressed (Table 2).

Table 2.

Relationship between self-efficacy, depression, and adherence to ART.

Variable  AdherenceOR (95%/CI)  p value 
  No AdherenceAdherence   
  N  N     
Self-efficacy
Low  30  16  13.3  2.330  0.044a
High  33  27.5  41  34.2  (1.089–4.983) 
Total  63  32.5  57  47.5   
Depression
Depression  37  30.8  16  13.3  3.647  0.001a
No depression  26  21.7  41  34.2  (1.697–7.837) 
Total  63  52.5  57  47.5   

Under Dr. H. Abdul Moeloek in Lampung (N=120).

a

α<0.05.

Discussion

This study revealed that 81.7% of participants undergoing ART were 18–40 years of age. Over the last 10 years, HIV transmission has shown a consistent pattern, tending to attack people aged 20–49 years (those categorized within the reproductive age range).1 Women at reproductive ages are more likely to engage in sexual activities, making them more likely to contract HIV. In addition, young women are greatly influenced by the gender roles and social norms that circulate in their communities; this reduces their ability to make their own decisions about their health and lives. Women infected with HIV could also be influenced by socioeconomic conditions. Difficulty in finding work sometimes motivates young women to engage in risky activities, such as becoming sex workers to meet their economic needs.16

This study found that women with high self-efficacy were associated with significantly better medication adherence. Self-efficacy is a multidimensional concept; it is defined as existing in PLWH who are confident in their ability to manage their HIV, believe that every problem can be controlled, and have the desire to overcome these problems (for example, by maintaining a treatment regimen).17 PLWH with high self-efficacy are able to manage the situation effectively, motivate themselves, and control their emotions so that they can handle their challenges. Their mindset strengthens them and helps them endure hardships.18 High self-efficacy can make PLWH confident in its treatment and follow their ART regimens. In this study, respondents’ self-perceptions were generally positive, and most respondents adhered to ART.19

The current findings show that depression is associated with adherence to ART. Several studies find that depressed patients may have negative beliefs about the importance of adherence; another explanation is that the negative side effects of ART may cause discomfort and open her HIV status. As a consequence, such patients may not follow ART regimens regularly.13 WLWH who are depressed often lessen takes ART. Similar research conducted in the Dominican Republic stated that its 80 HIV participants undergoing ART experienced two kinds of depression: a lack of interest in activities and low moods. Accordingly, they found it difficult to adhere to their treatment programs. People who are diagnosed with HIV and have to undergo ART for life could experience depression.20 Researchers argue that when WLWH are depressed, they feel helpless and have negative self-feelings, which decrease their motivation to care for themselves. As a result, they often overdose when taking drugs.

Research conducted in India in 2014 revealed that of the 85 participants studied, 25% were found to be depressed and not adherent to ART.21 These results are also supported by several other studies, which found that depression significantly affected patient adherence to antiretroviral therapy.22 Depression has also been shown to affect adherence to ART both in PLWH who have just begun ART and in those who have undergone it for more than 12 months.23 The present study was only conducted in one place Dr. H. Abdul Moeleok hospital in Lampung, so its samples were homogeneous and not overly varied.

The results reveal a significant relationship between self-efficacy, depression, and adherence to ART in women with HIV. Young women's sexual activity further increases the overall incidence of HIV in women. Training to improve self-efficacy and early screening for depression in HIV patients must be provided to improve their adherence to ART.

Conflict of interests

The authors declare no conflict of interest.

Acknowledgment

This work is supported by Hibah PITTA 2018 funded by DRPM Universitas Indonesia No. 1859/UN2.R3.1/HKP.05.00/2018.

References
[1]
Joint United Nations Programme on HIV/AIDS (UNAIDS).
UNAIDS DATA 2017. [Internet].
(2017),
[2]
Ministry of Health Republic of Indonesia.
Laporan Perkembangan HIV-AIDS & Penyakit Infeksi Menular Seksual Triwulan I Tahun 2017 [Internet].
(2017),
[3]
P.G. de Olalla, H. Knobel, A. Carmona, A. Guelar, J.L. López-Colomés, J.A. Caylà.
Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients.
J Acquir Immune Def Syndr, 30 (2002), pp. 105-110
[4]
WHO.
Antiretroviral therapy for HIV infection in adults and adolescents, recommendations for a public health approach, 2010 revision, vol. 4911, no. 866.
World Health Organization, (2010), pp. 117
[5]
E.M. Gardner, W.J. Burman, J.F. Steiner, P.L. Anderson, D.R. Bangsberg.
Antiretroviral medication adherence and the development of class-specific antiretroviral resistance.
AIDS, 23 (2009), pp. 1035-1046
[6]
WHO.
Adherence to long-term therapies: evidence for action.
World Health Organization [Internet]. WHO Library Cataloguing-in-Publication Data, (2003),
[7]
Valverde DW-, C. Dong, R.L. Ownby.
Medication-taking self-efficacy and medication adherence among HIV-infected cocaine users.
J Assoc Nurs AIDS Care, 24 (2013), pp. 198-206
[8]
N. Fentahun, A. Molla, B. Wondafrash.
Self-efficacy analysis among HIV positive patients specialized hospital: a cross-sectional study in Jimma University.
Asian Pac J Trop Biomed, 4 (2014), pp. 2-7
[9]
M.S. Wolf, T.C. Davis, C.Y. Osborn, S. Skripkauskas, C.L. Bennett, G. Makoul.
Literacy, self-efficacy, and HIV medication adherence.
Pat Educ Couns, 65 (2006), pp. 253-260
[10]
A. Bandura.
Self-efficacy: the exercise of control.
WH Freeman, (1997),
[11]
L.R. Brody, D.C. Jack, D.L. Bruck-Segal, E.G. Ruffing, Y.M. Firpo-Perretti, S.K. Dale, et al.
Life lessons from women with HIV: mutuality, self-awareness, and self-efficacy.
AIDS Pat Care STDs, 30 (2016), pp. 261-273
[12]
L. Rodkjaer, M.A. Chesney, K. Lomborg, L. Ostergaard, T. Laursen, M. Sodemann.
HIV-infected individuals with high coping self-efficacy are less likely to report depressive symptoms: a cross-sectional study from.
Int J Infect Dis, 22 (2013), pp. 67-72
[13]
M. Narváez, L. Lins, I. Reis, D. Oliveira, C. Brites.
Quality of life, anxiety and depression in patients with HIV/AIDS who present poor adherence to antiretroviral therapy: a cross-sectional study in.
Braz J Infect Dis, 21 (2017), pp. 507-514
[14]
V.A. Mello, A.A. Segurado, A. Malbergier.
Depression in women living with HIV: clinical and psychosocial correlates.
Arch Womens Ment Health, 13 (2010), pp. 193-199
[15]
M. Vyavaharkar, L. Moneyham, A. Tavakoli, K.D. Phillips, C. Murdaugh, K. Jackson, et al.
Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the Southeastern United States.
AIDS Pat Care STDs, 21 (2007), pp. 667-680
[16]
T. Türmen.
Gender and HIV/AIDS.
Int J Gynaecol Obstetr, 82 (2003), pp. 411-418
[17]
L. Huang.
Self-efficacy, medication adherence, and quality of life among people living with HIV in Hunan Province of China: a questionnaire survey.
J Assoc Nurs AIDS Care, 24 (2013), pp. 145-153
[18]
A. Bandura.
Social cognitive theory and exercise of control over HIV infection.
Preventing AIDS: theory methods behavioral interventions, pp. 25-59
[19]
A. Adefolalu, Z. Nkosi, S. Olorunju, P. Masemola.
Self-efficacy, medication beliefs and adherence to antiretroviral therapy by patients attending a health facility in Pretoria.
South African Fam Pract, 56 (2014), pp. 281-285
[20]
M. Koenig-Dzialowski, M. Wainberg, M. Halpern, A.N. Pala, R. Matic, W. Galvez-Castro.
Depression, substance abuse and antiretroviral non-adherence among adults with HIV in care at the Clínica de Familia in La Romana, Dominican Republic.
J Glob Health, VII (2016), pp. 11-16
[21]
R. Cook, D. Waldrop-Valverde, A. Sharma, S. Vamos, B. Mahajan, S.M. Weiss, et al.
Cognitive functioning, depression, and HIV medication adherence in India: a randomized pilot trial.
Health Psychol Behav Med, 2 (2014), pp. 640-652
[22]
J. Gonzalez, A. Batchelder, C. Parson, S. Safren.
Depression and HIV/AIDS treatment no adherence: a review and meta-analysis.
J Acquir Immune Def Syndr, 58 (2011), pp. 181-187
[23]
N.M. Belenky, S.R. Cole, B.W. Pence, D. Itemba, V. Maro, K. Whetten.
Depressive symptoms, HIV medication adherence, and HIV clinical outcomes in Tanzania: a prospective, observational study.

Peer-review under responsibility of the scientific committee of the Second International Nursing Scholar Congress (INSC 2018) of Faculty of Nursing, Universitas Indonesia. Full-text and the content of it is under responsibility of authors of the article.

Copyright © 2019. Elsevier España, S.L.U.. All rights reserved
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.